Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Carrier, G.
Right arrow Articles by Brunet, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carrier, G.
Right arrow Articles by Brunet, R. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences, Vol 47, 23-32, Copyright © 1999 by Society of Toxicology


ARTICLES

A toxicokinetic model to assess the risk of azinphosmethyl exposure in humans through measures of urinary elimination of alkylphosphates

G Carrier and RC Brunet
Departement de Medecine, Faculte de medecine, Universite de Montreal, Quebec, Canada.

Azinphosmethyl (APM) is one of the most common insecticides used in fruit farming. The object of this paper is to develop a quick and practical test for assessing the risk for humans coming into contact with APM. It has been shown that the principal component of occupational and/or accidental exposure is through the skin (C. A. Franklin et al., 1981, J. Toxicol. Environ. Health 7, 715-731), but our approach is applicable to exposures via any route or a combination of routes. The method proposed in the present paper can accommodate a single-event exposure or repeated exposures over long periods. Urinary alkylphosphate (AP) metabolites are reliable bioindicators of the presence of APM in the body; they are easily accessible and can be used to estimate APM body burden. We developed a simple toxicokinetic model to link the time varying APM body burden to absorbed doses and to rates of elimination in the form of AP urinary metabolites. Using this model and data available in the literature, we are able to propose a "no observed adverse effect level" (NOAEL) for APM body levels and for corresponding absorbed doses. We have established that after a single exposure, the safe limit corresponding to the NOAEL is reached at a cumulative 0.215 mumoles AP/kg bw eliminated in urine in the first 24 hours following the beginning of exposure. For repeated daily exposures at steady state, the corresponding urinary AP metabolite level is equal to a cumulative 0.266 mumoles AP/kg bw eliminated per 24 hours.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ANN OCCUP HYGHome page
M. BOUCHARD, G. CARRIER, R. C. BRUNET, P. DUMAS, and N. NOISEL
Biological Monitoring of Exposure to Organophosphorus Insecticides in a Group of Horticultural Greenhouse Workers
Ann. Hyg., July 1, 2006; 50(5): 505 - 515.
[Abstract] [Full Text] [PDF]


Home page
ANN OCCUP HYGHome page
N. H. GOSSELIN, R. C. BRUNET, G. CARRIER, and A. DOSSO
Worker Exposures to Triclopyr: Risk Assessment Through Measurements in Urine Samples
Ann. Hyg., July 1, 2005; 49(5): 415 - 422.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
F. M. Buratti, A. D'Aniello, M. T. Volpe, A. Meneguz, and E. Testai
MALATHION BIOACTIVATION IN THE HUMAN LIVER: THE CONTRIBUTION OF DIFFERENT CYTOCHROME P450 ISOFORMS
Drug Metab. Dispos., March 1, 2005; 33(3): 295 - 302.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. Bouchard, R. C. Brunet, P.-O. Droz, and G. Carrier
A Biologically Based Dynamic Model for Predicting the Disposition of Methanol and Its Metabolites in Animals and Humans
Toxicol. Sci., December 1, 2001; 64(2): 169 - 184.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. L. Rigas, M. S. Okino, and J. J. Quackenboss
Use of a Pharmacokinetic Model to Assess Chlorpyrifos Exposure and Dose in Children, Based on Urinary Biomarker Measurements
Toxicol. Sci., June 1, 2001; 61(2): 374 - 381.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.